Literature DB >> 8849016

Non-cardiac malformations in individuals with outflow tract defects of the heart: the Baltimore-Washington Infant Study (1981-1989).

I W Lurie1, A P Kappetein, C A Loffredo, C Ferencz.   

Abstract

In the Baltimore-Washington Infant Study, a regional case-control study of 4,390 liveborn infants with cardiovascular malformations (CVM), 642 patients (14.2%) had outflow tract abnormalities, with extracardiac defects in 157 (approximately 25%) of them. Associated defects were found in 1/3 of patients with normal great arteries, but only in 1/10 of patients with transposition of great arteries (TGA). The extracardiac defects were especially rare in the groups "TGA with intact ventricular septum" and "TGA with ventricular septal defect". Patients with multiple associated defects outnumbered patients with isolated associated defects in the ratio 2.5:1. The associated defects were heterogeneous: 46 patients had chromosome abnormalities, 16 had different Mendelian syndromes, and 36 had associations (DiGeorge sequence and VACTERL association were the most frequent). A new syndrome of multiple congenital abnormalities including tetralogy of Fallot, and rare cases of chromosomal and Mendelian syndromes (distal trisomy 1q, tetrasomy 8p, Holzgreve syndrome) are described briefly. Sufficient variability of a spectrum of conotruncal defects in the patients with the same chromosomal or Mendelian syndromes suggests that at least in some cases different conotruncal defects are stages of the same morphologic spectrum. The analysis of conotruncal defects in sibs of patients with Mendelian syndromes may provide new data about the links between different definitive forms of CVM.

Entities:  

Mesh:

Year:  1995        PMID: 8849016     DOI: 10.1002/ajmg.1320590116

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  Critical congenital heart disease--utility of routine screening for chromosomal and other extracardiac malformations.

Authors:  Kimberly Baker; Joan Sanchez-de-Toledo; Ricardo Munoz; Richard Orr; Shareen Kiray; Dana Shiderly; Michele Clemens; Peter Wearden; Victor O Morell; Constantinos Chrysostomou
Journal:  Congenit Heart Dis       Date:  2011-11-09       Impact factor: 2.007

2.  The role of the sagittal view of the ductal arch in identification of fetuses with conotruncal anomalies using 4-dimensional ultrasonography.

Authors:  Jimmy Espinoza; Roberto Romero; Juan Pedro Kusanovic; Francesca Gotsch; Offer Erez; Wesley Lee; Luís F Gonçalves; Mary Lou Schoen; Sonia S Hassan
Journal:  J Ultrasound Med       Date:  2007-09       Impact factor: 2.153

3.  Search for 22q11 deletion in non-syndromic conotruncal cardiac defects.

Authors:  M C Digilio; B Marino; A Giannotti; B Dallapiccola
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

4.  Chromosomal Abnormalities Affect the Surgical Outcome in Infants with Hypoplastic Left Heart Syndrome: A Large Cohort Analysis.

Authors:  Dala Zakaria; Xinyu Tang; Rupal Bhakta; Nahed O ElHassan; Parthak Prodhan
Journal:  Pediatr Cardiol       Date:  2017-09-18       Impact factor: 1.655

5.  Patterns of cardiac and extracardiac anomalies in adults with tetralogy of fallot.

Authors:  Sara Piran; Anne S Bassett; Jasmine Grewal; Jodi-Ann Swaby; Chantal Morel; Erwin N Oechslin; Andrew N Redington; Peter P Liu; Candice K Silversides
Journal:  Am Heart J       Date:  2011-01       Impact factor: 4.749

6.  Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study.

Authors:  C Tennstedt; R Chaoui; H Körner; M Dietel
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

7.  Late detection of critical congenital heart disease among US infants: estimation of the potential impact of proposed universal screening using pulse oximetry.

Authors:  Cora Peterson; Elizabeth Ailes; Tiffany Riehle-Colarusso; Matthew E Oster; Richard S Olney; Cynthia H Cassell; David E Fixler; Suzan L Carmichael; Gary M Shaw; Suzanne M Gilboa
Journal:  JAMA Pediatr       Date:  2014-04       Impact factor: 16.193

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.